vs
Side-by-side financial comparison of Dexcom (DXCM) and PLEXUS CORP (PLXS). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $1.1B, roughly 1.2× PLEXUS CORP). Dexcom runs the higher net margin — 21.2% vs 3.8%, a 17.4% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 9.6%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 7.9%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
Plex Systems, Inc. is an American software company based in Troy, Michigan. The company develops and markets the Plex Manufacturing Cloud, a software as a service (SaaS) or cloud computing ERP for manufacturing.
DXCM vs PLXS — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.1B |
| Net Profit | $267.3M | $41.2M |
| Gross Margin | 62.9% | 9.9% |
| Operating Margin | 25.6% | 5.1% |
| Net Margin | 21.2% | 3.8% |
| Revenue YoY | 21.6% | 9.6% |
| Net Profit YoY | 153.6% | -19.9% |
| EPS (diluted) | $0.67 | $1.51 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | $1.1B | ||
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.0B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $994.2M | — | ||
| Q2 24 | $1.0B | — |
| Q1 26 | $267.3M | $41.2M | ||
| Q4 25 | $267.3M | — | ||
| Q3 25 | $283.8M | — | ||
| Q2 25 | $179.8M | — | ||
| Q1 25 | $105.4M | — | ||
| Q4 24 | $151.7M | — | ||
| Q3 24 | $134.6M | — | ||
| Q2 24 | $143.5M | — |
| Q1 26 | 62.9% | 9.9% | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
| Q1 26 | 25.6% | 5.1% | ||
| Q4 25 | 25.6% | — | ||
| Q3 25 | 20.1% | — | ||
| Q2 25 | 18.4% | — | ||
| Q1 25 | 12.9% | — | ||
| Q4 24 | 17.0% | — | ||
| Q3 24 | 15.3% | — | ||
| Q2 24 | 15.7% | — |
| Q1 26 | 21.2% | 3.8% | ||
| Q4 25 | 21.2% | — | ||
| Q3 25 | 23.5% | — | ||
| Q2 25 | 15.5% | — | ||
| Q1 25 | 10.2% | — | ||
| Q4 24 | 13.6% | — | ||
| Q3 24 | 13.5% | — | ||
| Q2 24 | 14.3% | — |
| Q1 26 | $0.67 | $1.51 | ||
| Q4 25 | $0.67 | — | ||
| Q3 25 | $0.70 | — | ||
| Q2 25 | $0.45 | — | ||
| Q1 25 | $0.27 | — | ||
| Q4 24 | $0.37 | — | ||
| Q3 24 | $0.34 | — | ||
| Q2 24 | $0.35 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $248.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | $1.5B |
| Total Assets | $6.3B | $3.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | $248.8M | ||
| Q4 25 | $917.7M | — | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $904.9M | — | ||
| Q4 24 | $606.1M | — | ||
| Q3 24 | $621.2M | — | ||
| Q2 24 | $939.2M | — |
| Q1 26 | $2.7B | $1.5B | ||
| Q4 25 | $2.7B | — | ||
| Q3 25 | $2.7B | — | ||
| Q2 25 | $2.6B | — | ||
| Q1 25 | $2.3B | — | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.0B | — | ||
| Q2 24 | $2.4B | — |
| Q1 26 | $6.3B | $3.2B | ||
| Q4 25 | $6.3B | — | ||
| Q3 25 | $7.5B | — | ||
| Q2 25 | $7.3B | — | ||
| Q1 25 | $6.8B | — | ||
| Q4 24 | $6.5B | — | ||
| Q3 24 | $6.4B | — | ||
| Q2 24 | $6.8B | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXCM
Segment breakdown not available.
PLXS
| Asia-Pacific | $612.0M | 57% |
| Americas | $345.0M | 32% |
| Europe, Middle East and Africa | $118.0M | 11% |
